Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages-Reference-Cited by-同舟云学术

Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages

Published:2011-12-21 Issue:5 Volume:86 Page:2715-2728
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:Journal of Virology

Author:

Ochsenbauer C.,Edmonds T. G.,Ding H.,Keele B. F.,Decker J.,Salazar M. G.,Salazar-Gonzalez J. F.,Shattock R.,Haynes B. F.,Shaw G. M.,Hahn B. H.,Kappes J. C.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference71 articles.

1. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants;Abrahams;J. Virol.,2009

2. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1;Alkhatib;Science,1996

3. Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?;Ayinde;Retrovirology,2010

4. Wide variation in the multiplicity of HIV-1 infection among injection drug users;Bar;J. Virol.,2010

5. Host hindrance to HIV-1 replication in monocytes and macrophages;Bergamaschi;Retrovirology,2010

Cited by 301 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity;Journal of Virology;2024-09-09

2. The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC;2024-08-27

3. QuickFit: A High-Throughput RT-qPCR-Based Assay to Quantify Viral Growth and Fitness In Vitro;Viruses;2024-08-19

4. NTB-A and 2B4 Natural Killer Cell Receptors Modulate the Capacity of a Cocktail of Non-Neutralizing Antibodies and a Small CD4-Mimetic to Eliminate HIV-1-Infected Cells by Antibody-Dependent Cellular Cytotoxicity;Viruses;2024-07-20

5. HIV broadly neutralizing antibody escapability drives the therapeutic efficacy of vectored immunotherapy;2024-07-12